I
Igor Dvorchik
Researcher at University of Pittsburgh
Publications - 72
Citations - 5509
Igor Dvorchik is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Transplantation & Liver transplantation. The author has an hindex of 39, co-authored 72 publications receiving 5280 citations. Previous affiliations of Igor Dvorchik include Mayo Clinic & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system
Shunzaburo Iwatsuki,Igor Dvorchik,Juan Madariaga,J. Wallis Marsh,Forrest Dodson,Andrew Bonham,David A. Geller,Timothy Gayowski,John J. Fung,Thomas E. Starzl +9 more
TL;DR: In this paper, the authors used the Cox proportional hazards model to estimate the survival rate for metastatic colorectal cancer using 305 consecutive patients who underwent primary hepatic resections for melanoma.
Journal ArticleDOI
Clinical Intestinal Transplantation: A Decade of Experience at a Single Center
Kareem Abu-Elmagd,Jorge Reyes,Geoffrey Bond,George V. Mazariegos,Tong Wu,Noriko Murase,Rakesh Sindhi,D Martin,Joanne Colangelo,Marsha Zak,Douglas Janson,Mohamed Ezzelarab,Igor Dvorchik,Maria Parizhskaya,Melvin Deutsch,Anthony J. Demetris,John J. Fung,Thomas E. Starzl +17 more
TL;DR: The survival rates after intestinal transplantation have cumulatively improved during the past decade, and with the management strategies currently under evaluation, intestinal transplant procedures have the potential to become the standard of care for patients with end-stage intestinal failure.
Journal ArticleDOI
Liver Transplantation Using Donation After Cardiac Death Donors: Long-Term Follow-Up from a Single Center
M. E. de Vera,R Lopez-Solis,Igor Dvorchik,S Campos,W Morris,Anthony J. Demetris,Paulo Fontes,J. W. Marsh +7 more
TL;DR: There was a lack of survival benefit in DCD livers utilized in patients with model for end‐stage liver disease (MELD) ≤30 or those not on organ‐perfusion support, as graft survival was significantly lower compared to DBD patients, however, DCD and DBD subjects transplanted with MELD >30 or on organ-perfusions support had similar graft survival, suggesting a potentially greater benefit of DCDLivers in critically ill patients.
Journal ArticleDOI
Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation
Shunzaburo Iwatsuki,Satoru Todo,J. Wallis Marsh,Juan Madariaga,Randall G. Lee,Igor Dvorchik,John J. Fung,Thomas E. Starzl +7 more
TL;DR: Satisfactory longterm survivals can be obtained by curative surgery for hilar cholangiocarcinoma either with hepatic resection or liver transplantation or with curative intent.
Journal ArticleDOI
Is the pathologic TNM staging system for patients with hepatoma predictive of outcome
TL;DR: The current pathologic TNM classification system was not found to be predictive for patients undergoing orthotopic liver transplantation (OLTx) in the presence of hepatocellular carcinoma (HCC).